A detailed history of Jpmorgan Chase & CO transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Jpmorgan Chase & CO holds 58,976 shares of BIO stock, worth $21.8 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
58,976
Previous 38,211 54.34%
Holding current value
$21.8 Million
Previous $13.2 Million 21.87%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

BUY
$268.26 - $339.48 $5.57 Million - $7.05 Million
20,765 Added 54.34%
58,976 $16.1 Million
Q1 2024

May 10, 2024

SELL
$304.11 - $351.99 $2.48 Million - $2.87 Million
-8,153 Reduced 17.58%
38,211 $13.2 Million
Q4 2023

Feb 12, 2024

BUY
$269.37 - $365.04 $2.28 Million - $3.09 Million
8,469 Added 22.35%
46,364 $15 Million
Q3 2023

Nov 14, 2023

SELL
$350.25 - $422.63 $2 Million - $2.41 Million
-5,698 Reduced 13.07%
37,895 $13.6 Million
Q2 2023

Aug 11, 2023

BUY
$359.49 - $486.4 $446,846 - $604,595
1,243 Added 2.94%
43,593 $16.5 Million
Q1 2023

May 18, 2023

BUY
$418.69 - $503.0 $4.24 Million - $5.09 Million
10,127 Added 31.43%
42,350 $20.3 Million
Q1 2023

May 11, 2023

SELL
$418.69 - $503.0 $396,918 - $476,844
-948 Reduced 2.86%
32,223 $15.4 Million
Q4 2022

Feb 13, 2023

SELL
$351.71 - $456.01 $1.8 Million - $2.34 Million
-5,131 Reduced 13.4%
33,171 $13.9 Million
Q3 2022

Nov 14, 2022

SELL
$412.59 - $563.26 $1.51 Million - $2.06 Million
-3,662 Reduced 8.73%
38,302 $16 Million
Q2 2022

Aug 11, 2022

BUY
$463.67 - $597.16 $2.29 Million - $2.94 Million
4,929 Added 13.31%
41,964 $20.8 Million
Q1 2022

May 11, 2022

BUY
$524.57 - $735.42 $3.3 Million - $4.63 Million
6,296 Added 20.48%
37,035 $20.9 Million
Q4 2021

Feb 10, 2022

BUY
$708.84 - $794.68 $406,165 - $455,351
573 Added 1.9%
30,739 $23.2 Million
Q3 2021

Nov 12, 2021

BUY
$657.71 - $825.77 $19.8 Million - $24.9 Million
30,166 New
30,166 $22.5 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $9.09B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.